AbDiver: a tool to explore the natural antibody landscape to aid therapeutic design

Abstract Motivation Rational design of therapeutic antibodies can be improved by harnessing the natural sequence diversity of these molecules. Our understanding of the diversity of antibodies has recently been greatly facilitated through the deposition of hundreds of millions of human antibody seque...

Full description

Saved in:
Bibliographic Details
Published inBioinformatics (Oxford, England) Vol. 38; no. 9; pp. 2628 - 2630
Main Authors Młokosiewicz, Jakub, Deszyński, Piotr, Wilman, Wiktoria, Jaszczyszyn, Igor, Ganesan, Rajkumar, Kovaltsuk, Aleksandr, Leem, Jinwoo, Galson, Jacob D, Krawczyk, Konrad
Format Journal Article
LanguageEnglish
Published England Oxford University Press 28.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Motivation Rational design of therapeutic antibodies can be improved by harnessing the natural sequence diversity of these molecules. Our understanding of the diversity of antibodies has recently been greatly facilitated through the deposition of hundreds of millions of human antibody sequences in next-generation sequencing (NGS) repositories. Contrasting a query therapeutic antibody sequence to naturally observed diversity in similar antibody sequences from NGS can provide a mutational roadmap for antibody engineers designing biotherapeutics. Because of the sheer scale of the antibody NGS datasets, performing queries across them is computationally challenging. Results To facilitate harnessing antibody NGS data, we developed AbDiver (http://naturalantibody.com/abdiver), a free portal allowing users to compare their query sequences to those observed in the natural repertoires. AbDiver offers three antibody-specific use-cases: (i) compare a query antibody to positional variability statistics precomputed from multiple independent studies, (ii) retrieve close full variable sequence matches to a query antibody and (iii) retrieve CDR3 or clonotype matches to a query antibody. We applied our system to a set of 742 therapeutic antibodies, demonstrating that for each use-case our system can retrieve relevant results for most sequences. AbDiver facilitates the navigation of vast antibody mutation space for the purpose of rational therapeutic antibody design. Availability and implementation AbDiver is freely accessible at http://naturalantibody.com/abdiver. Supplementary information Supplementary data are available at Bioinformatics online.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1367-4803
1367-4811
DOI:10.1093/bioinformatics/btac151